ACell®, Inc. Announces Addition of Sally Maher, JD to Board of Directors


Columbia, MD – (October 31, 2016) – ACell, Inc. today announced that Sally Maher, JD has joined the company’s Board of Directors. Maher is currently Edwards Lifesciences’ Vice President of Regulatory and Clinical Affairs, Critical Care. Prior to Edwards, she served as Senior Vice President, Compliance and Government Affairs, for Smith & Nephew Endoscopy.

“Sally brings extensive experience in Regulatory Affairs, Clinical Research, Compliance, Business Development, Reimbursement, and Quality Control for industry-leading device and pharmaceutical companies to ACell’s Board. Her background complements ACell’s current Board of Directors, and her knowledgeable oversight will surely have a positive influence on the company’s strategic direction,” said Kyle Kerbawy, ACell’s Chairman of the Board.

Maher will replace James Osborne on the ACell Board of Directors. Mr. Osborne will continue to advise ACell as a consultant on the current medical device reimbursement landscape.

“I am enthusiastic about the opportunity to join the Board of a dynamic company like ACell that is focused on innovative, market-changing solutions in wound care and surgical soft tissue repair. As ACell continues to advance its product development, expand its body of clinical research, and cultivate a dynamic product portfolio, I look forward to sharing my experience and guidance to support the company’s ongoing growth as it advances patient care,” said Maher.

Maher has also held positions with Johnson & Johnson, Pfizer Hospital Products Groups, and the US Food and Drug Administration. She has a BA in Bacteriology from Ohio Wesleyan University and a JD from the University of Baltimore.

About ACell, Inc.

ACell, Inc. is a leading regenerative medicine company focused on the development, manufacturing and commercialization of unique proprietary extracellular matrix (ECM) products to facilitate the repair and remodeling of damaged tissues. ACell is committed to becoming and remaining an innovative leader in regenerative medical technology, offering superior healing options for doctors and patients. ACell is a privately held company and operates manufacturing facilities in Columbia, MD and Lafayette, IN. For more information, call 800-826-2926 or visit www.acell.com.

Download a PDF of this article

Return to News